Novo Nordisk Aktie
42,10
EUR
+0,35
EUR
+0,83
%
42,20
EUR
+0,38
EUR
+0,90
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 11.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.21 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
| 03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.01.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |
| 01.12.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.11.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 30.10.20 | Novo Nordisk kaufen | Bernstein Research | |
| 30.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 30.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
| 07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.07.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.05.20 | Novo Nordisk overweight | Barclays Capital | |
Werbung
Werbung